Hisamitsu Pharmaceutical Co., Inc. (4530.T)

JPY 4423.0

(0.52%)

Revenue Summary of Hisamitsu Pharmaceutical Co., Inc.

  • Hisamitsu Pharmaceutical Co., Inc.'s latest annual revenue in 2023 was 141.7 Billion JPY , up 10.42% from previous year.
  • Hisamitsu Pharmaceutical Co., Inc.'s latest quarterly revenue in 2024 Q1 was 35.81 Billion JPY , down -7.89% from previous quarter.
  • Hisamitsu Pharmaceutical Co., Inc. reported a annual revenue of 128.33 Billion JPY in annual revenue 2022, up 6.77% from previous year.
  • Hisamitsu Pharmaceutical Co., Inc. reported a annual revenue of 120.19 Billion JPY in annual revenue 2021, up 4.96% from previous year.
  • Hisamitsu Pharmaceutical Co., Inc. reported a quarterly revenue of 35.81 Billion JPY for 2024 Q1, down -7.89% from previous quarter.
  • Hisamitsu Pharmaceutical Co., Inc. reported a quarterly revenue of 32.09 Billion JPY for 2023 Q1, down -11.94% from previous quarter.

Annual Revenue Chart of Hisamitsu Pharmaceutical Co., Inc. (2023 - 2004)

Historical Annual Revenue of Hisamitsu Pharmaceutical Co., Inc. (2023 - 2004)

Year Revenue Revenue Growth
2023 141.7 Billion JPY 10.42%
2022 128.33 Billion JPY 6.77%
2021 120.19 Billion JPY 4.96%
2020 114.51 Billion JPY -18.78%
2019 140.99 Billion JPY -1.68%
2018 143.4 Billion JPY -3.02%
2017 147.87 Billion JPY 1.33%
2016 145.92 Billion JPY -9.84%
2015 161.85 Billion JPY 3.26%
2014 156.74 Billion JPY 4.05%
2013 150.63 Billion JPY 5.51%
2012 142.77 Billion JPY 3.61%
2011 137.79 Billion JPY 0.44%
2010 137.18 Billion JPY 5.66%
2009 129.83 Billion JPY 4.15%
2008 124.65 Billion JPY 4.7%
2007 119.06 Billion JPY 8.44%
2006 109.79 Billion JPY 6.94%
2005 102.66 Billion JPY 22.89%
2004 83.54 Billion JPY 0.0%

Peer Revenue Comparison of Hisamitsu Pharmaceutical Co., Inc.

Name Revenue Revenue Difference
Pharma Foods International Co., Ltd. 62.14 Billion JPY -128.017%
Takeda Pharmaceutical Company Limited 4263.76 Billion JPY 96.677%
Sumitomo Pharma Co., Ltd. 314.55 Billion JPY 54.951%
Shionogi & Co., Ltd. 435.08 Billion JPY 67.43%
Wakamoto Pharmaceutical Co.,Ltd. 7.73 Billion JPY -1731.199%
Nippon Shinyaku Co., Ltd. 148.25 Billion JPY 4.417%
Kaken Pharmaceutical Co., Ltd. 72.04 Billion JPY -96.694%
Eisai Co., Ltd. 741.75 Billion JPY 80.896%
Morishita Jintan Co., Ltd. 12.4 Billion JPY -1042.238%
Mochida Pharmaceutical Co., Ltd. 102.88 Billion JPY -37.732%
Fuso Pharmaceutical Industries,Ltd. 55.4 Billion JPY -155.759%
Nippon Chemiphar Co., Ltd. 30.74 Billion JPY -360.862%
Tsumura & Co. 150.84 Billion JPY 6.059%
Kissei Pharmaceutical Co., Ltd. 75.57 Billion JPY -87.494%
Torii Pharmaceutical Co., Ltd. 54.63 Billion JPY -159.354%
Towa Pharmaceutical Co., Ltd. 227.93 Billion JPY 37.83%
Fuji Pharma Co., Ltd. 40.88 Billion JPY -246.563%
Zeria Pharmaceutical Co., Ltd. 75.72 Billion JPY -87.132%
KYORIN Holdings, Inc. 119.53 Billion JPY -18.551%
Taiko Pharmaceutical Co.,Ltd. 5.04 Billion JPY -2711.627%
Daito Pharmaceutical Co.,Ltd. 46.89 Billion JPY -202.177%
SymBio Pharmaceuticals Limited 5.58 Billion JPY -2435.123%
MedRx Co., Ltd 26 Million JPY -544923.077%
Mizuho Medy Co.,Ltd. 10.98 Billion JPY -1189.44%
Solasia Pharma K.K. 617 Million JPY -22866.937%
Modalis Therapeutics Corporation - JPY -Infinity%
ASKA Pharmaceutical Holdings Co.,Ltd. 62.84 Billion JPY -125.492%
Sawai Group Holdings Co., Ltd. 176.86 Billion JPY 19.878%
Cyfuse Biomedical K.K. 61.11 Million JPY -231779.173%
Toho Holdings Co., Ltd. 1476.71 Billion JPY 90.404%
Koa Shoji Holdings Co.,Ltd. 22.13 Billion JPY -540.214%